Cargando…
Fibrinolysis with Lower Dose Urokinase in Patients with Complicated Parapneumonic Effusion
BACKGROUND: Intrapleural urokinase is one of the most widely used fibrinolytic agents in the treatment of complicated parapneumonic effusion (CPPE). However, little research has been performed on the optimal urokinase dosage. The aim of this study was to evaluate the treatment efficacy of half dose...
Autores principales: | Lee, Seul, Lee, Heock, Lee, Dong Hyun, Kang, Bo Hyoung, Roh, Mee Sook, Son, Choohee, Kim, Sung Hyun, Lee, Hyun-Kyung, Um, Soo-Jung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Tuberculosis and Respiratory Diseases
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010421/ https://www.ncbi.nlm.nih.gov/pubmed/33327051 http://dx.doi.org/10.4046/trd.2020.0018 |
Ejemplares similares
-
A case of Lemierre's syndrome with septic shock and complicated parapneumonic effusions requiring intrapleural fibrinolysis
por: Croft, Daniel P., et al.
Publicado: (2015) -
Treatment of complicated parapneumonic pleural effusion and pleural parapneumonic empyema
por: Suárez, Pedro Rodríguez, et al.
Publicado: (2012) -
Intrapleural Tenecteplase for Complicated Parapneumonic Pleural Effusion
por: Kadhem, Husain, et al.
Publicado: (2021) -
Intrapleural therapy in management of complicated parapneumonic effusions and empyema
por: Ahmed, AlaEldin H, et al.
Publicado: (2010) -
Surgical management of complicated parapneumonic pleural effusion in children
por: BUDUSAN, ANCA, et al.
Publicado: (2013)